Attached files
| file | filename |
|---|---|
| EX-10.6 - EX-10.6 - OSIRIS THERAPEUTICS, INC. | a2234906zex-10_6.htm |
| 10-K - 10-K - OSIRIS THERAPEUTICS, INC. | a2234906z10-k.htm |
| EX-31.2.1 - EX-31.2.1 - OSIRIS THERAPEUTICS, INC. | a2234906zex-31_21.htm |
| EX-31.1.1 - EX-31.1.1 - OSIRIS THERAPEUTICS, INC. | a2234906zex-31_11.htm |
| EX-23.1.1 - EX-23.1.1 - OSIRIS THERAPEUTICS, INC. | a2234906zex-23_11.htm |
| EX-21 - EX-21 - OSIRIS THERAPEUTICS, INC. | a2234906zex-21.htm |
| EX-10.9 - EX-10.9 - OSIRIS THERAPEUTICS, INC. | a2234906zex-10_9.htm |
| EX-10.5 - EX-10.5 - OSIRIS THERAPEUTICS, INC. | a2234906zex-10_5.htm |
| EX-3.2 - EX-3.2 - OSIRIS THERAPEUTICS, INC. | a2234906zex-3_2.htm |
QuickLinks -- Click here to rapidly navigate through this document
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Osiris Therapeutics, Inc., (the "Company"), does hereby certify, to the best of each officer's knowledge that:
The Annual Report on Form 10-K for the years ended December 31, 2015, December 31, 2016 and December 31, 2017 (the "Form 10-K") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 28, 2018 | /s/ JASON KEEFER Jason Keefer, Interim Chief Executive Officer |
|
Date: March 28, 2018 |
/s/ LINDA L. CHANG Linda L. Chang, Chief Financial Officer |
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)